| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 15 | 2025 | 1377 | 3.730 |
Why?
|
| Colorectal Neoplasms | 5 | 2024 | 512 | 2.330 |
Why?
|
| Lung Neoplasms | 7 | 2024 | 495 | 1.830 |
Why?
|
| Emergency Service, Hospital | 6 | 2025 | 278 | 1.780 |
Why?
|
| Registries | 7 | 2025 | 437 | 1.690 |
Why?
|
| Electronic Health Records | 7 | 2023 | 108 | 1.210 |
Why?
|
| SEER Program | 7 | 2024 | 164 | 1.150 |
Why?
|
| Healthcare Disparities | 7 | 2025 | 590 | 1.130 |
Why?
|
| Visual Cortex | 4 | 2025 | 64 | 1.110 |
Why?
|
| Humans | 87 | 2025 | 43102 | 1.080 |
Why?
|
| Breast Neoplasms | 9 | 2025 | 1723 | 1.070 |
Why?
|
| United States | 23 | 2025 | 5205 | 1.060 |
Why?
|
| Aged | 41 | 2025 | 8214 | 1.010 |
Why?
|
| Medicare | 5 | 2025 | 332 | 0.960 |
Why?
|
| Female | 63 | 2025 | 24698 | 0.950 |
Why?
|
| Insurance Claim Review | 1 | 2025 | 37 | 0.880 |
Why?
|
| Poverty | 2 | 2024 | 400 | 0.840 |
Why?
|
| Male | 47 | 2025 | 23409 | 0.820 |
Why?
|
| Housing | 1 | 2024 | 74 | 0.800 |
Why?
|
| Middle Aged | 41 | 2025 | 12222 | 0.780 |
Why?
|
| Aged, 80 and over | 19 | 2025 | 2853 | 0.780 |
Why?
|
| Social Class | 3 | 2022 | 291 | 0.780 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 50 | 0.740 |
Why?
|
| Hospitals | 7 | 2015 | 117 | 0.710 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 497 | 0.710 |
Why?
|
| California | 10 | 2025 | 548 | 0.700 |
Why?
|
| Adult | 38 | 2025 | 13872 | 0.680 |
Why?
|
| Rural Population | 1 | 2024 | 373 | 0.680 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 133 | 0.660 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 158 | 0.600 |
Why?
|
| Incidence | 11 | 2025 | 1078 | 0.600 |
Why?
|
| Age of Onset | 3 | 2024 | 114 | 0.560 |
Why?
|
| Death Certificates | 1 | 2018 | 15 | 0.550 |
Why?
|
| Maternal Exposure | 1 | 2018 | 57 | 0.540 |
Why?
|
| Smoking | 4 | 2022 | 1024 | 0.530 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 67 | 0.520 |
Why?
|
| Mexican Americans | 1 | 2019 | 226 | 0.510 |
Why?
|
| Premature Birth | 1 | 2018 | 95 | 0.500 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 140 | 0.500 |
Why?
|
| Selection Bias | 2 | 2022 | 13 | 0.490 |
Why?
|
| Arthroplasty, Replacement, Knee | 3 | 2020 | 14 | 0.470 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2014 | 367 | 0.460 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 449 | 0.460 |
Why?
|
| Prostatic Neoplasms | 2 | 2024 | 1092 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 760 | 0.440 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 18 | 0.440 |
Why?
|
| Health Status Disparities | 5 | 2021 | 719 | 0.430 |
Why?
|
| Quality Assurance, Health Care | 4 | 2015 | 55 | 0.420 |
Why?
|
| Sex Factors | 5 | 2024 | 1028 | 0.410 |
Why?
|
| Patient Compliance | 2 | 2015 | 233 | 0.410 |
Why?
|
| Home Care Services | 1 | 2014 | 37 | 0.410 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2024 | 11 | 0.400 |
Why?
|
| Disease Management | 1 | 2014 | 70 | 0.400 |
Why?
|
| Diabetes Complications | 1 | 2014 | 102 | 0.390 |
Why?
|
| Wound Healing | 1 | 2014 | 88 | 0.390 |
Why?
|
| Cuba | 2 | 2024 | 33 | 0.370 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 193 | 0.370 |
Why?
|
| Melanoma | 1 | 2013 | 110 | 0.360 |
Why?
|
| Risk Factors | 10 | 2021 | 3994 | 0.340 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 178 | 0.340 |
Why?
|
| Work Schedule Tolerance | 1 | 2010 | 4 | 0.340 |
Why?
|
| Age Factors | 4 | 2024 | 1154 | 0.340 |
Why?
|
| Lighting | 1 | 2010 | 12 | 0.330 |
Why?
|
| North Carolina | 3 | 2025 | 127 | 0.320 |
Why?
|
| Geological Phenomena | 1 | 2010 | 4 | 0.320 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 830 | 0.320 |
Why?
|
| Occupational Diseases | 1 | 2010 | 53 | 0.320 |
Why?
|
| Geologic Sediments | 1 | 2010 | 46 | 0.310 |
Why?
|
| Rivers | 1 | 2010 | 51 | 0.310 |
Why?
|
| Health Services Accessibility | 2 | 2025 | 706 | 0.300 |
Why?
|
| Phosphorus | 1 | 2010 | 65 | 0.300 |
Why?
|
| Cross-Cultural Comparison | 2 | 2014 | 111 | 0.300 |
Why?
|
| Retrospective Studies | 7 | 2023 | 2544 | 0.300 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2021 | 163 | 0.280 |
Why?
|
| Critical Illness | 3 | 2019 | 47 | 0.280 |
Why?
|
| Neoplasm Staging | 3 | 2024 | 374 | 0.280 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 224 | 0.270 |
Why?
|
| Water | 1 | 2010 | 316 | 0.270 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 167 | 0.250 |
Why?
|
| Survivors | 2 | 2019 | 152 | 0.240 |
Why?
|
| Peer Group | 2 | 2019 | 177 | 0.240 |
Why?
|
| Patients | 2 | 2016 | 16 | 0.240 |
Why?
|
| Cohort Studies | 7 | 2025 | 1759 | 0.240 |
Why?
|
| Survival Rate | 2 | 2019 | 355 | 0.230 |
Why?
|
| Safety Management | 2 | 2015 | 17 | 0.220 |
Why?
|
| Young Adult | 11 | 2021 | 5080 | 0.220 |
Why?
|
| Marital Status | 1 | 2024 | 46 | 0.210 |
Why?
|
| Critical Pathways | 2 | 2014 | 18 | 0.210 |
Why?
|
| Endometrial Neoplasms | 2 | 2015 | 79 | 0.210 |
Why?
|
| Social Support | 2 | 2019 | 445 | 0.210 |
Why?
|
| Algorithms | 2 | 2025 | 509 | 0.210 |
Why?
|
| Nerve Net | 1 | 2025 | 101 | 0.210 |
Why?
|
| Forecasting | 1 | 2024 | 136 | 0.200 |
Why?
|
| Proportional Hazards Models | 5 | 2024 | 518 | 0.200 |
Why?
|
| Epidemiologic Methods | 1 | 2023 | 56 | 0.200 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2023 | 15 | 0.200 |
Why?
|
| Teaching | 1 | 2003 | 59 | 0.190 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 231 | 0.190 |
Why?
|
| Hospital Administration | 4 | 2015 | 9 | 0.190 |
Why?
|
| Air Pollution | 1 | 2023 | 87 | 0.190 |
Why?
|
| Europe | 7 | 2015 | 115 | 0.190 |
Why?
|
| Prejudice | 1 | 2003 | 116 | 0.190 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2022 | 53 | 0.190 |
Why?
|
| Basal Ganglia | 1 | 2022 | 21 | 0.190 |
Why?
|
| Nursing Staff, Hospital | 2 | 2014 | 21 | 0.180 |
Why?
|
| Hallucinogens | 1 | 2022 | 29 | 0.180 |
Why?
|
| Air Pollutants | 1 | 2023 | 130 | 0.180 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2003 | 95 | 0.180 |
Why?
|
| Prospective Studies | 7 | 2025 | 1600 | 0.180 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2022 | 64 | 0.180 |
Why?
|
| Neurons | 3 | 2025 | 1263 | 0.180 |
Why?
|
| Neurogenesis | 1 | 2022 | 63 | 0.180 |
Why?
|
| Comorbidity | 1 | 2024 | 737 | 0.180 |
Why?
|
| Marijuana Smoking | 1 | 2022 | 91 | 0.170 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 81 | 0.170 |
Why?
|
| Age Distribution | 1 | 2021 | 249 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 184 | 0.170 |
Why?
|
| Cannabis | 1 | 2022 | 90 | 0.170 |
Why?
|
| Mortality | 2 | 2019 | 175 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 989 | 0.160 |
Why?
|
| Validation Studies as Topic | 1 | 2020 | 8 | 0.160 |
Why?
|
| Adolescent | 9 | 2022 | 6081 | 0.160 |
Why?
|
| Hospitalization | 3 | 2019 | 485 | 0.160 |
Why?
|
| Population Surveillance | 1 | 2021 | 246 | 0.160 |
Why?
|
| Veterans | 1 | 2022 | 210 | 0.150 |
Why?
|
| Arthralgia | 1 | 2019 | 12 | 0.150 |
Why?
|
| Postoperative Complications | 2 | 2015 | 263 | 0.150 |
Why?
|
| Mobility Limitation | 1 | 2019 | 21 | 0.150 |
Why?
|
| Osteoarthritis, Knee | 1 | 2019 | 15 | 0.150 |
Why?
|
| South America | 1 | 2019 | 24 | 0.150 |
Why?
|
| Mice | 5 | 2025 | 6644 | 0.150 |
Why?
|
| Action Potentials | 1 | 2021 | 246 | 0.150 |
Why?
|
| Visual Pathways | 1 | 2019 | 40 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2019 | 58 | 0.150 |
Why?
|
| Soft Tissue Infections | 1 | 2018 | 6 | 0.150 |
Why?
|
| Organizational Culture | 2 | 2015 | 15 | 0.140 |
Why?
|
| Clinical Competence | 2 | 2014 | 156 | 0.140 |
Why?
|
| Mammography | 2 | 2024 | 212 | 0.140 |
Why?
|
| Quality Control | 2 | 2015 | 42 | 0.140 |
Why?
|
| Cross-Sectional Studies | 9 | 2022 | 3156 | 0.140 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 31 | 0.140 |
Why?
|
| Brain Mapping | 1 | 2019 | 137 | 0.140 |
Why?
|
| Aortic Diseases | 1 | 2018 | 34 | 0.140 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 46 | 0.140 |
Why?
|
| Cause of Death | 2 | 2018 | 186 | 0.140 |
Why?
|
| Reward | 2 | 2016 | 112 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2018 | 135 | 0.140 |
Why?
|
| Educational Status | 2 | 2013 | 339 | 0.140 |
Why?
|
| Medical Staff, Hospital | 2 | 2015 | 15 | 0.140 |
Why?
|
| Quality of Life | 2 | 2019 | 616 | 0.130 |
Why?
|
| Weight Gain | 2 | 2015 | 139 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 102 | 0.130 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 120 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 375 | 0.130 |
Why?
|
| Pilot Projects | 3 | 2015 | 760 | 0.130 |
Why?
|
| Survival Analysis | 3 | 2013 | 368 | 0.130 |
Why?
|
| Contracts | 1 | 2016 | 1 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 1001 | 0.130 |
Why?
|
| Drug Synergism | 1 | 2017 | 195 | 0.120 |
Why?
|
| Internet | 2 | 2016 | 236 | 0.120 |
Why?
|
| Patient Participation | 2 | 2015 | 94 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1081 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2016 | 224 | 0.120 |
Why?
|
| Cost of Illness | 1 | 2016 | 98 | 0.120 |
Why?
|
| Critical Care | 1 | 2016 | 49 | 0.120 |
Why?
|
| Carboxypeptidase H | 1 | 2015 | 6 | 0.120 |
Why?
|
| Stroke | 3 | 2015 | 340 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2015 | 16 | 0.120 |
Why?
|
| Hospital Charges | 1 | 2015 | 15 | 0.120 |
Why?
|
| Leiomyosarcoma | 1 | 2015 | 3 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2024 | 863 | 0.120 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 59 | 0.120 |
Why?
|
| Hysterectomy | 1 | 2015 | 38 | 0.120 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2015 | 12 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 30 | 0.120 |
Why?
|
| Drug Monitoring | 1 | 2016 | 69 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2015 | 16 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2015 | 27 | 0.110 |
Why?
|
| Laparoscopy | 1 | 2015 | 59 | 0.110 |
Why?
|
| Cooperative Behavior | 2 | 2015 | 269 | 0.110 |
Why?
|
| Logistic Models | 2 | 2017 | 1009 | 0.110 |
Why?
|
| Pregnancy | 2 | 2018 | 1772 | 0.110 |
Why?
|
| Contraceptive Agents, Female | 1 | 2015 | 25 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2018 | 972 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 32 | 0.110 |
Why?
|
| Pregnancy in Adolescence | 1 | 2015 | 34 | 0.110 |
Why?
|
| Mental Health | 1 | 2019 | 385 | 0.110 |
Why?
|
| Appointments and Schedules | 1 | 2015 | 32 | 0.110 |
Why?
|
| San Francisco | 1 | 2014 | 35 | 0.110 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2014 | 23 | 0.110 |
Why?
|
| Binomial Distribution | 1 | 2014 | 1 | 0.110 |
Why?
|
| Occult Blood | 1 | 2014 | 32 | 0.110 |
Why?
|
| Puerto Rico | 1 | 2019 | 1413 | 0.110 |
Why?
|
| Obesity | 2 | 2015 | 1151 | 0.110 |
Why?
|
| Probability | 1 | 2014 | 82 | 0.110 |
Why?
|
| Hospital Administrators | 1 | 2014 | 2 | 0.110 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 53 | 0.110 |
Why?
|
| Papillomaviridae | 2 | 2006 | 142 | 0.110 |
Why?
|
| Communication Barriers | 1 | 2014 | 60 | 0.110 |
Why?
|
| Animals | 6 | 2025 | 16992 | 0.110 |
Why?
|
| Proxy | 1 | 2014 | 7 | 0.110 |
Why?
|
| Patient Discharge | 3 | 2019 | 128 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 83 | 0.110 |
Why?
|
| Evidence-Based Nursing | 1 | 2014 | 2 | 0.110 |
Why?
|
| Health Status | 2 | 2018 | 442 | 0.110 |
Why?
|
| Checklist | 1 | 2014 | 17 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2014 | 122 | 0.100 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 50 | 0.100 |
Why?
|
| Gene Expression | 1 | 2017 | 701 | 0.100 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 1063 | 0.100 |
Why?
|
| Nurses | 1 | 2014 | 55 | 0.100 |
Why?
|
| Developed Countries | 1 | 2013 | 16 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 49 | 0.100 |
Why?
|
| Rural Health | 1 | 2014 | 55 | 0.100 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 23 | 0.100 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2013 | 21 | 0.100 |
Why?
|
| Birth Rate | 1 | 2013 | 6 | 0.100 |
Why?
|
| Time Factors | 3 | 2024 | 1857 | 0.100 |
Why?
|
| Child Mortality | 1 | 2013 | 11 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 148 | 0.100 |
Why?
|
| Cultural Competency | 1 | 2014 | 138 | 0.100 |
Why?
|
| Maternal Mortality | 1 | 2013 | 26 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 75 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 64 | 0.100 |
Why?
|
| Leadership | 1 | 2013 | 86 | 0.100 |
Why?
|
| Developing Countries | 1 | 2013 | 113 | 0.100 |
Why?
|
| Exercise | 1 | 2019 | 692 | 0.100 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 31 | 0.100 |
Why?
|
| Language | 1 | 2014 | 185 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2014 | 142 | 0.100 |
Why?
|
| Aging | 1 | 2018 | 783 | 0.100 |
Why?
|
| Austria | 1 | 2012 | 5 | 0.100 |
Why?
|
| Prognosis | 3 | 2022 | 861 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 1234 | 0.090 |
Why?
|
| Causality | 1 | 2012 | 45 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 104 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 749 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 704 | 0.090 |
Why?
|
| Motivation | 1 | 2016 | 513 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 80 | 0.090 |
Why?
|
| Analgesics, Opioid | 2 | 2011 | 252 | 0.090 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2011 | 3 | 0.090 |
Why?
|
| Physicians | 1 | 2014 | 188 | 0.090 |
Why?
|
| Research Design | 1 | 2014 | 385 | 0.090 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2011 | 1 | 0.090 |
Why?
|
| Peptic Ulcer | 1 | 2011 | 15 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2011 | 23 | 0.090 |
Why?
|
| Naloxone | 1 | 2011 | 56 | 0.090 |
Why?
|
| Narcotic Antagonists | 1 | 2011 | 78 | 0.090 |
Why?
|
| Indoles | 1 | 2013 | 187 | 0.090 |
Why?
|
| Intensive Care Units | 3 | 2019 | 72 | 0.080 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 101 | 0.080 |
Why?
|
| Morphine | 1 | 2011 | 69 | 0.080 |
Why?
|
| Moving and Lifting Patients | 1 | 2010 | 1 | 0.080 |
Why?
|
| Dexmedetomidine | 1 | 2010 | 2 | 0.080 |
Why?
|
| Health Behavior | 1 | 2014 | 575 | 0.080 |
Why?
|
| Acrylates | 1 | 2010 | 8 | 0.080 |
Why?
|
| Fentanyl | 1 | 2010 | 16 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2010 | 27 | 0.080 |
Why?
|
| Health Promotion | 1 | 2016 | 704 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2016 | 661 | 0.080 |
Why?
|
| Respiration | 1 | 2009 | 56 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 110 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2009 | 90 | 0.070 |
Why?
|
| Exercise Therapy | 1 | 2009 | 87 | 0.070 |
Why?
|
| Walking | 1 | 2009 | 88 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 236 | 0.070 |
Why?
|
| Texas | 1 | 2010 | 457 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2018 | 1546 | 0.060 |
Why?
|
| Education, Nursing, Graduate | 1 | 2006 | 5 | 0.060 |
Why?
|
| Nursing | 1 | 2006 | 5 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2013 | 587 | 0.060 |
Why?
|
| Pain | 1 | 2009 | 290 | 0.060 |
Why?
|
| Cognition | 1 | 2010 | 473 | 0.060 |
Why?
|
| Mouth | 1 | 2006 | 54 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2006 | 37 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 539 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2014 | 575 | 0.060 |
Why?
|
| Hip Fractures | 2 | 2015 | 29 | 0.060 |
Why?
|
| Atlases as Topic | 1 | 2024 | 7 | 0.060 |
Why?
|
| Temporal Lobe | 1 | 2024 | 26 | 0.060 |
Why?
|
| Delayed Diagnosis | 1 | 2024 | 38 | 0.050 |
Why?
|
| Curriculum | 2 | 2006 | 318 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2025 | 138 | 0.050 |
Why?
|
| Australia | 1 | 2004 | 103 | 0.050 |
Why?
|
| European Union | 2 | 2014 | 6 | 0.050 |
Why?
|
| Turkey | 2 | 2014 | 23 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2025 | 161 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2025 | 136 | 0.050 |
Why?
|
| Risk | 1 | 2024 | 287 | 0.050 |
Why?
|
| China | 1 | 2004 | 229 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2025 | 341 | 0.050 |
Why?
|
| Contraception | 1 | 2004 | 60 | 0.050 |
Why?
|
| Research Personnel | 1 | 2025 | 206 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2023 | 1285 | 0.050 |
Why?
|
| New Zealand | 1 | 2003 | 32 | 0.050 |
Why?
|
| Papillomavirus Infections | 2 | 2006 | 376 | 0.050 |
Why?
|
| Infant | 2 | 2018 | 1175 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 154 | 0.050 |
Why?
|
| Respiration, Artificial | 2 | 2015 | 44 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2013 | 1604 | 0.050 |
Why?
|
| Child | 3 | 2018 | 3443 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2023 | 83 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 247 | 0.050 |
Why?
|
| Astrocytes | 1 | 2024 | 244 | 0.050 |
Why?
|
| Microglia | 1 | 2024 | 208 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 81 | 0.050 |
Why?
|
| Breast | 1 | 2023 | 139 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 59 | 0.050 |
Why?
|
| Nomograms | 1 | 2022 | 14 | 0.050 |
Why?
|
| Body Weight | 2 | 2015 | 429 | 0.050 |
Why?
|
| Disease Progression | 1 | 2024 | 667 | 0.040 |
Why?
|
| Genotype | 1 | 2004 | 800 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2003 | 359 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2022 | 104 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2013 | 490 | 0.040 |
Why?
|
| Medical Record Linkage | 1 | 2021 | 17 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2013 | 317 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2023 | 256 | 0.040 |
Why?
|
| Thalamus | 1 | 2021 | 34 | 0.040 |
Why?
|
| Nurse's Role | 2 | 2014 | 37 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2021 | 138 | 0.040 |
Why?
|
| Photic Stimulation | 1 | 2021 | 125 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2011 | 183 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2020 | 73 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 719 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2019 | 20 | 0.040 |
Why?
|
| Public Opinion | 1 | 2019 | 20 | 0.040 |
Why?
|
| Censuses | 1 | 2019 | 28 | 0.040 |
Why?
|
| Happiness | 1 | 2019 | 16 | 0.040 |
Why?
|
| Women | 1 | 2019 | 28 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 541 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2004 | 638 | 0.040 |
Why?
|
| Semantics | 1 | 2019 | 29 | 0.040 |
Why?
|
| Cities | 1 | 2019 | 79 | 0.040 |
Why?
|
| Aortography | 1 | 2018 | 10 | 0.040 |
Why?
|
| Physical Examination | 1 | 2018 | 45 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 35 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 27 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 238 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2019 | 122 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 735 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 234 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 73 | 0.030 |
Why?
|
| Calibration | 1 | 2016 | 63 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2015 | 18 | 0.030 |
Why?
|
| Lymphedema | 1 | 2015 | 7 | 0.030 |
Why?
|
| Urinary Tract | 1 | 2015 | 8 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2016 | 91 | 0.030 |
Why?
|
| Neoplasm Seeding | 1 | 2015 | 5 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2015 | 31 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 94 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 21 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 22 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2015 | 8 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1869 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 48 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 118 | 0.030 |
Why?
|
| Family Planning Services | 1 | 2015 | 34 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2015 | 43 | 0.030 |
Why?
|
| Robotics | 1 | 2015 | 43 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 71 | 0.030 |
Why?
|
| Hospital Departments | 1 | 2014 | 3 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 165 | 0.030 |
Why?
|
| Energy Intake | 1 | 2015 | 164 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 229 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 174 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2015 | 112 | 0.030 |
Why?
|
| Genomics | 1 | 2016 | 293 | 0.030 |
Why?
|
| Physician's Role | 1 | 2014 | 40 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2013 | 2 | 0.030 |
Why?
|
| Maternal Welfare | 1 | 2013 | 7 | 0.030 |
Why?
|
| Population Growth | 1 | 2013 | 8 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2013 | 23 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2014 | 98 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 210 | 0.030 |
Why?
|
| Africa | 1 | 2013 | 82 | 0.030 |
Why?
|
| Suicide | 1 | 2015 | 140 | 0.020 |
Why?
|
| Carcinogenicity Tests | 1 | 2013 | 5 | 0.020 |
Why?
|
| Goals | 1 | 2013 | 34 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 310 | 0.020 |
Why?
|
| Urban Population | 1 | 2015 | 374 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2016 | 420 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 281 | 0.020 |
Why?
|
| Retreatment | 1 | 2011 | 11 | 0.020 |
Why?
|
| Pruritus | 1 | 2011 | 4 | 0.020 |
Why?
|
| Antipruritics | 1 | 2011 | 3 | 0.020 |
Why?
|
| Antiemetics | 1 | 2011 | 8 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 405 | 0.020 |
Why?
|
| Nausea | 1 | 2011 | 12 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 734 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 53 | 0.020 |
Why?
|
| Vomiting | 1 | 2011 | 14 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 58 | 0.020 |
Why?
|
| Eating | 1 | 2013 | 167 | 0.020 |
Why?
|
| Health Policy | 1 | 2013 | 184 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 863 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 140 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 193 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 115 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 173 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 241 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 440 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 284 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 1067 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1612 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1124 | 0.020 |
Why?
|
| Professional Practice | 1 | 2006 | 6 | 0.020 |
Why?
|
| Faculty, Nursing | 1 | 2006 | 6 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2006 | 21 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2006 | 34 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 3735 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2006 | 311 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2006 | 139 | 0.010 |
Why?
|
| HIV Infections | 1 | 2013 | 2586 | 0.010 |
Why?
|